Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A PolyPid Ltd. Filed by: Rosalind Advisors, Inc.

May 12, 2026 11:25 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: This percentage is calculated based upon 18,204,002 Ordinary shares of the Issuers common stock outstanding as of December 31, 2025, based on the press release issued by Polypid Ltd on February 11, 2026, titled "Polypid Provides Corporate update and reports fourth quarter and full-year 2025 financial results". However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 597,926 shares of Common Stock 4,786,887 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 597,926 shares of Common Stock 4,786,887 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 597,926 shares of Common Stock 4,786,887 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 597,926 shares of Common Stock 4,786,887 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:05/12/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:05/12/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:05/12/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:05/12/2026

ATTACHMENTS / EXHIBITS

rosalind_pypd_exa.htm

Categories

SEC Filings